Blood zinc decreased
(UMLS:C0855675)
- UMLS ID:
- C0855675
- MeSH ID:
- N/A
Synonym(s)
1.
Blood zinc decreased
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Furosemide | FAERS: 4 | US FAERS | |
| 2 | Atorvastatin | FAERS: 2 | US FAERS | |
| 3 | Estradiol | FAERS: 2 | US FAERS | |
| 4 | carbidopa, levodopa drug combination | FAERS: 2 | US FAERS | |
| 5 | Axitinib | FAERS: 1 | US FAERS | |
| 6 | Azithromycin | FAERS: 1 | US FAERS | |
| 7 | Ezetimibe | FAERS: 1 | US FAERS | |
| 8 | Finasteride | FAERS: 1 | US FAERS | |
| 9 | Fluoxetine | FAERS: 1 | US FAERS | |
| 10 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 11 | Levetiracetam | FAERS: 1 | US FAERS | |
| 12 | Losartan | FAERS: 1 | US FAERS | |
| 13 | Methylphenidate | FAERS: 1 | US FAERS | |
| 14 | Minocycline | FAERS: 1 | US FAERS | |
| 15 | Nexium 24hr | FAERS: 1 | US FAERS | |
| 16 | Thyroxine | FAERS: 1 | US FAERS | |
| 17 | Valsartan | FAERS: 1 | US FAERS | |
| 18 | apremilast | FAERS: 1 | US FAERS | |
| 19 | palbociclib | FAERS: 1 | US FAERS | |
| 20 | pazopanib | FAERS: 1 | US FAERS | |
| 21 | sapropterin | FAERS: 1 | US FAERS | |
| 22 | teriflunomide | FAERS: 1 | US FAERS | |
| 23 | Bimatoprost | OFFSIDES | ||
| 24 | Clozapine | OFFSIDES | ||
| 25 | Imipramine | OFFSIDES | ||
| 26 | Lamivudine | OFFSIDES | ||
| 27 | Lopinavir/Ritonavir | OFFSIDES | ||
| 28 | Milnacipran | OFFSIDES | ||
| 29 | Pentamidine | OFFSIDES | ||
| 30 | Ranitidine | OFFSIDES | ||
| 31 | Sodium picosulfate | OFFSIDES | ||
| 32 | Vitamin D | OFFSIDES | ||
| 33 | Zidovudine | OFFSIDES | ||
| 34 | abacavir | OFFSIDES | ||
| 35 | dexamethasone 21-phosphate | OFFSIDES | ||
| 36 | etizolam | OFFSIDES | ||
| 37 | lafutidine | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.